Chevy Chase Trust
CRBU icon

Chevy Chase Trust’s Caribou Biosciences CRBU Stock Holding History

Chevy Chase Trust’s Portfolio CRBU Stock Details CRBU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$19K Hold
10,000
– – ﹤0.01% 642
2025
Q4 		$15.9K Hold
10,000
– – ﹤0.01% 638
2025
Q3 		$23.3K Hold
10,000
– – ﹤0.01% 628
2025
Q2 		$12.6K Hold
10,000
– – ﹤0.01% 633
2025
Q1 		$9.13K Buy
+10,000
New +$13K ﹤0.01% 633

Other funds holding CRBU

P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Chevy Chase Trust's CRBU Position: Q1 2026 in Review

Chevy Chase Trust held its Caribou Biosciences (CRBU) position steady in Q1 2026 at 10,000 shares worth $19K. The position accounts for ﹤0.01% of the portfolio, ranked #642.

Chevy Chase Trust first reported a position in CRBU in Q1 2025 and has held it in 5 quarters since. The position peaked at $23.3K in Q3 2025. 137 funds tracked by Wall St. Rank hold CRBU as of Q1 2026.

  • Chevy Chase Trust held 10,000 shares of Caribou Biosciences worth $19K as of Q1 2026.
  • Chevy Chase Trust left its Caribou Biosciences share count unchanged in Q1 2026.
  • Caribou Biosciences made up ﹤0.01% of Chevy Chase Trust's portfolio in Q1 2026, its #642 holding.
  • Chevy Chase Trust first reported a position in Caribou Biosciences in Q1 2025 and has held it in 5 quarters since.
  • Chevy Chase Trust's Caribou Biosciences position peaked at $23.3K in Q3 2025.
  • 137 funds tracked by Wall St. Rank held Caribou Biosciences as of Q1 2026.

Based on Chevy Chase Trust's 13F filing for Q1 2026, filed 15 May 2026.